Colloid carcinoma (cc) is a rare but distinct subtype of pancreatic cancer, revealing favorable outcomes compared to tubular carcinoma (tc).

• CC accounts for 25% of invasive intraductal papillary mucinous neoplasms.
• Patients with cc were more often male (70%), and had a higher prevalence of steatorrhea (26%) and diabetes (44%).
• Median overall survival for cc is significantly longer at 69 months compared to 31 months for tc.

Surgeons should recognize cc’s unique features to improve prognostic assessments and personalize management strategies.